Creo Medical Group PLC (CREO) - Total Liabilities

Latest as of December 2025: GBX9.10 Million GBX ≈ $1.11K USD

Based on the latest financial reports, Creo Medical Group PLC (CREO) has total liabilities worth GBX9.10 Million GBX (≈ $1.11K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CREO long-term investment intensity to see how much of total assets are deployed in long-term investments.

Creo Medical Group PLC - Total Liabilities Trend (2005–2025)

This chart illustrates how Creo Medical Group PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Creo Medical Group PLC (CREO) total assets.

Creo Medical Group PLC Competitors by Total Liabilities

The table below lists competitors of Creo Medical Group PLC ranked by their total liabilities.

Company Country Total Liabilities
Gemfields Plc
LSE:GEM
UK GBX206.14 Million
Lucky Minerals Inc
V:LKY
Canada CA$8.24 Million
Aesthetic Medical International Holdings Group Limited
NASDAQ:PAIYY
USA $554.12 Million
RightBridge Ventures Group AB
ST:RIGHTB
Sweden Skr15.38 Million
ARCTIC BLUE BEVERAGES AB
F:U5L
Germany €23.26 Million
Tongyang Inc
KO:001527
Korea ₩712.72 Billion
Kollect on Demand Holding Ab
ST:KOLL
Sweden Skr10.37 Million
TTL Beteiligungs- und Grundbesitz-AG
F:TTO
Germany €64.46 Million

Liability Composition Analysis (2005–2025)

This chart breaks down Creo Medical Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Creo Medical Group PLC's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Creo Medical Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Creo Medical Group PLC (2005–2025)

The table below shows the annual total liabilities of Creo Medical Group PLC from 2005 to 2025.

Year Total Liabilities Change
2025-12-31 GBX9.10 Million
≈ $1.11K
-59.73%
2024-12-31 GBX22.60 Million
≈ $2.75K
+34.52%
2023-12-31 GBX16.80 Million
≈ $2.04K
-35.22%
2022-12-31 GBX25.93 Million
≈ $3.16K
-4.97%
2021-12-31 GBX27.29 Million
≈ $3.32K
-7.98%
2020-12-31 GBX29.66 Million
≈ $3.61K
+429.58%
2019-12-31 GBX5.60 Million
≈ $681.39
+175.45%
2018-12-31 GBX2.03 Million
≈ $247.37
-11.22%
2018-06-30 GBX2.29 Million
≈ $278.63
+55.67%
2017-06-30 GBX1.47 Million
≈ $178.99
+86.50%
2016-06-30 GBX788.81K
≈ $95.98
+48.05%
2016-02-29 GBX532.79K
≈ $64.83
+80.01%
2015-02-28 GBX295.98K
≈ $36.01
+18.30%
2014-02-28 GBX250.20K
≈ $30.44
+331.38%
2008-02-29 GBX58.00K
≈ $7.06
-76.33%
2007-02-28 GBX245.00K
≈ $29.81
+49.39%
2006-02-28 GBX164.00K
≈ $19.95
+864.71%
2005-02-28 GBX17.00K
≈ $2.07
--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices
Market Cap
$724.08K
GBX5.95 Billion GBX
Market Cap Rank
#30871 Global
#864 in UK
Share Price
GBX12.25
Change (1 day)
+0.00%
52-Week Range
GBX9.90 - GBX17.75
All Time High
GBX243.00
About

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices del… Read more